Publisher
Springer Nature Switzerland
Reference21 articles.
1. Anderson Cancer Center. (2020). Chimeric antigen receptor (CAR) cell therapy toxicity assessment and management – Adult. https://www.mdanderson.org/documents/for-physicians/algorithms/clinical-management/clin-management-cytokine-release-web-algorithm.pdf
2. Anderson K, Latchford T. Associated toxicities: assessment and management related to CAR T-cell therapy. Clin J Oncol Nurs. 2019;23(2):13–9. https://doi.org/10.1188/19.CJON.S1.13-19.
3. Brudno JN, Kochenderfer JN. Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev. 2019;34:45–55. https://doi.org/10.1016/j.blre.2018.11.002.
4. Clinical Care Options. (2019). A clinician’s guide to assessment and management of CAR T-cell toxicities. https://www.clinicaloptions.com/oncology/programs/car-t-cell-toxicities/downloadable-pdf/pdf-download
5. Coiffier B, Lepage E, Brière J, Herbrecht R, Tilly H, Bouabdallah R, Morel P, Van Den Neste E, Salles G, Gaulard P, Reyes F, Lederlin P, Lederlin P, Gisselbrecht C. CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma. N Engl J Med. 2002;346:235–42. https://www.nejm.org/doi/full/10.1056/nejmoa011795.